Outcome of fertility-preserving treatment in young women with endometrial carcinomas

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 3, 2005, Pages 317-320

  Niwa, K ^a   Tagami, K ^a   Lian, Z ^a   Onogi, K ^a   Mori, H ^a   Tamaya, T ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CURETTAGE; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE FERTILITY; FERTILITY; FOLLOW UP; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA; CARCINOMA, ADENOSQUAMOUS; COHORT STUDIES; COMBINED MODALITY THERAPY; DILATATION AND CURETTAGE; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFERTILITY, FEMALE; MEDROXYPROGESTERONE 17-ACETATE; NEOPLASM RECURRENCE, LOCAL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 14644401082     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00398.x     Document Type: Article

References (15)

1. Crissman JD, Azoury RS, Barnes AE, Schellhas HF. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 1981;57:699-704.
2. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal woman. Cancer 1997;79:320-327.
3. Fechner RE, Kaufman RH. Endometrial adenocarcinoma in premenopausal women. Cancer 1997;34:444-452.
4. Thornton JG, Brown LA, Wells M, Scoot JS. Primary treatment of endometrial cancer with progestogen alone. Lancet 1985;2:207-208.
5. Bokhman JV, Chepick OF, Volk AT, Vishnevsky AS. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 1985;20:139-155.
6. Farhi DC, Nosanchuk J, Silverberg SG. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 1986;68:741-745.
7. Kimmig R, Strowitzki T, Muller-Hocker J, Kurzl R, Korell M, Hepp H. Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 1995;58:255-257.
8. Niwa K, Yokoyama Y, Tanaka T, et al. Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Arch Gynecol Obstet 1994;255:91-94.
9. Niwa K, Morishita S, Hashimoto M, Yokoyama Y, Tamaya T. Conservative therapy for endometrial carcinoma in young women treated with curettage and progestogen. Int J Clin Oncol 1997;2:165-169.
10. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547-2559.
11. Creasman WT, Scoper JT, McCarty Jr KS, McCarty Sr KS, Hinshaw W, Clarke-Pearson DL. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol 1985;151:922-932.
12. Gotlieb WH, Beiner ME, Shalmon B, et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003;102:718-725.
13. Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-718.
14. Thigpen JT, Brandy MF, Alvarez RD, et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 1999;17:1736-1744.
15. Cresaman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. Cancer 1987;60:2035-2041.